Home General Biotechnology Drug Patent Expirations in June 2011

Drug Patent Expirations in June 2011

Drug Patent Expirations in June 2011

*Drugs may be covered by multiple patents



TradenameApplicantGeneric NamePatent NumberPatent Expiration
FEMARANovartis Pharmsletrozole4,978,672Jun 3, 2011
TAZORACAllergantazarotene5,089,509Jun 13, 2011
AVAGEAllergantazarotene5,089,509Jun 13, 2011
NUEDEXTAAvanir Pharmsdextromethorphan hydrobromide; quinidine sulfate5,166,207Jun 17, 2011
PATADAYAlconolopatadine hydrochloride5,116,863*PEDJun 18, 2011
PATANOLAlconolopatadine hydrochloride5,116,863*PEDJun 18, 2011
PATANASEAlconolopatadine hydrochloride5,116,863*PEDJun 18, 2011
LEVAQUINOrtho Mcneil Janssenlevofloxacin5,053,407*PEDJun 20, 2011
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINEROrtho Mcneil Pharmlevofloxacin5,053,407*PEDJun 20, 2011
LEVAQUINOrtho Mcneil Pharmlevofloxacin5,053,407*PEDJun 20, 2011
DILTIAZEM HYDROCHLORIDEBiovaildiltiazem hydrochloride5,288,505Jun 26, 2011
BAYCOLBayer Pharmscerivastatin sodium5,006,530Jun 26, 2011
CARDIZEM LABiovail Labs Intldiltiazem hydrochloride5,288,505Jun 26, 2011
COVERA-HSGd Searle Llcverapamil hydrochloride5,160,744Jun 27, 2011
COVERA-HSGd Searle Llcverapamil hydrochloride5,252,338Jun 27, 2011
ELIGARDTolmar Therapleuprolide acetate5,324,519Jun 28, 2011
LIPITORPfizeratorvastatin calciumRE40667*PEDJun 28, 2011
LIPITORPfizeratorvastatin calcium5,273,995*PEDJun 28, 2011
CADUETPfizeramlodipine besylate; atorvastatin calcium5,273,995*PEDJun 28, 2011
CADUETPfizeramlodipine besylate; atorvastatin calciumRE40667*PEDJun 28, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply